Contact
searchSearch
HMP Global
Login

Blogs Landing Page

Blogs

Quality Outlook
Measuring Justice in Breast Cancer Screening: A Bioethical Framework for Analyzing Quality Measures
03/10/2026
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality...
03/10/2026
Journal of Clinical Pathways
Quality Outlook
The Rising and Setting of Health Equity
02/24/2026
David Sloan, PhD; Tom Valuck, MD, JD
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating...
02/24/2026
Journal of Clinical Pathways
Quality Outlook
Autonomy in End-of-Life Cancer Care Measurement: A Bioethical Framework for Analyzing Quality Measures
09/24/2025
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
The predominant US health care quality measure development and endorsement processes, as summarized in the Center for Medicare and Medicaid Services (CMS) Blueprint, have various well-accepted criteria for evaluating measures. This blog...
The predominant US health care quality measure development and endorsement processes, as summarized in the Center for Medicare and Medicaid Services (CMS) Blueprint, have various well-accepted criteria for evaluating measures. This blog...
The predominant US health care...
09/24/2025
Journal of Clinical Pathways
Nandita Ammanamanchi
Quality Outlook
Beneficence and Nonmaleficence in Cancer Pain Measurement: A Bioethical Framework for Analyzing Quality Measures
07/21/2025
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series explores how the twin pillars of beneficence and nonmaleficence guide more ethical and effective measurement of cancer pain, balancing patient relief with the imperative to "first, do no harm."
This entry of the Quality Outlook blog series explores how the twin pillars of beneficence and nonmaleficence guide more ethical and effective measurement of cancer pain, balancing patient relief with the imperative to "first, do no harm."
This entry of the Quality...
07/21/2025
Journal of Clinical Pathways
Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Bridget Doherty, MPH, MS; Silas Martin, MS; Tom Valuck, MD, JD
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
David Blaisdell
Quality Outlook
Measuring Adherence to Oral Anticancer Medications: A Persistent Problem
06/06/2024
Tom Valuck, MD, JD; David Blaisdell, BA
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the...
06/06/2024
Journal of Clinical Pathways
Veronica Ellis
Quality Outlook
Transform HIV Prevention in Your Practice With a New Quality Initiative
05/01/2024
Tom Valuck, MD, JD
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an...
05/01/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Tom Valuck, MD, JD
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
Tom Valuck, MD, JD; Erik Muther; Theresa Schmidt, MA, PMP, CSPO; Danny Bellet, MBA; Donna Dugan, PhD, MS; David Sloan, PhD
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways

Editor Insights

Quality Outlook
Measuring Justice in Breast Cancer Screening: A Bioethical Framework for Analyzing Quality Measures
03/10/2026
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality...
03/10/2026
Journal of Clinical Pathways
Quality Outlook
The Rising and Setting of Health Equity
02/24/2026
David Sloan, PhD; Tom Valuck, MD, JD
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating...
02/24/2026
Journal of Clinical Pathways
Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Bridget Doherty, MPH, MS; Silas Martin, MS; Tom Valuck, MD, JD
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Tom Valuck, MD, JD
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
Tom Valuck, MD, JD; Erik Muther; Theresa Schmidt, MA, PMP, CSPO; Danny Bellet, MBA; Donna Dugan, PhD, MS; David Sloan, PhD
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023
David Blaisdell, BA; Tom Valuck, MD, JD
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023
Tom Valuck, MD, JD; Jacqlyn Riposo, MBA
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023
David Blaisdell, BA; Tom Valuck, MD, JD; Sarena Ho, MSPH
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Quality Outlook
Measuring Justice in Breast Cancer Screening: A Bioethical Framework for Analyzing Quality Measures
03/10/2026
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality...
03/10/2026
Journal of Clinical Pathways
Quality Outlook
The Rising and Setting of Health Equity
02/24/2026
David Sloan, PhD; Tom Valuck, MD, JD
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating...
02/24/2026
Journal of Clinical Pathways
Blog
CPC+CBEx 2025 Abstracts: Business Models, Breakthrough Tools, and Data-Driven Decisions Driving the Future of Cancer Care
08/27/2025
The 2025 Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), to be held September 5-6 in Boston, will confront these challenges head-on through 13 powerful abstracts that demonstrate what it takes to translate evidence into...
The 2025 Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), to be held September 5-6 in Boston, will confront these challenges head-on through 13 powerful abstracts that demonstrate what it takes to translate evidence into...
The 2025 Clinical Pathways...
08/27/2025
Journal of Clinical Pathways
Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Bridget Doherty, MPH, MS; Silas Martin, MS; Tom Valuck, MD, JD
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
Blog
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
08/07/2024
Winston Wong, PharmD
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together...
08/07/2024
Journal of Clinical Pathways
Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024
Winston Wong, PharmD
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Tom Valuck, MD, JD
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
Tom Valuck, MD, JD; Erik Muther; Theresa Schmidt, MA, PMP, CSPO; Danny Bellet, MBA; Donna Dugan, PhD, MS; David Sloan, PhD
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways

Data Science for HCPs

Data Science for HCPs
The Guardrails of Data Science: Regulations and Certifications for Health Care
01/20/2021
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael...
01/20/2021
Journal of Clinical Pathways
Data Science for HCPs
Finding the Signal in the Noise During COVID-19: A Survey on Multiple Sclerosis
06/25/2020
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and...
06/25/2020
Journal of Clinical Pathways
Data Science for HCPs
Extraction, Transformation, and Loading: The ETL of Data Engineering
05/18/2020
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and...
05/18/2020
Journal of Clinical Pathways
Data Science for HCPs
Data Engineering: The Foundation of Data Science Efforts
04/09/2020
Erwan Rivet, MBA, MSME; Victor M. Gehman, PhD; Kelly Leyden, MRes; Michael Becich, MS; Anisha Keshavan, PhD; Amal Katrib, PhD; Fatima Rubio da Costa, PhD; David Hughes, BSN; David Whewell
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and...
04/09/2020
Journal of Clinical Pathways
Data Science for HCPs
What Is Data Science: Addressing the Uncertainty Behind Addressing Uncertainty
03/14/2020
David Hughes, BSN; Victor M. Gehman, PhD; Michael Becich, MS; Amal Katrib, PhD; Fatima Rubio da Costa, PhD; David Whewell
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and...
03/14/2020
Journal of Clinical Pathways
Data Science for HCPs
Introduction to Data Science for Health Care Professionals
02/11/2020
Victor M. Gehman, PhD; Kelly Leyden, MRes; Michael Becich, MS; Anisha Keshavan, PhD; Amal Katrib, PhD; Melinda Thomas; Fatima Rubio da Costa, PhD; Michael Towbin; David Whewell; David Hughes, BSN
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the...
02/11/2020
Journal of Clinical Pathways
Data Science for HCPs
The Guardrails of Data Science: Regulations and Certifications for Health Care
01/20/2021
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael...
01/20/2021
Journal of Clinical Pathways
Data Science for HCPs
Finding the Signal in the Noise During COVID-19: A Survey on Multiple Sclerosis
06/25/2020
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and...
06/25/2020
Journal of Clinical Pathways
Data Science for HCPs
Extraction, Transformation, and Loading: The ETL of Data Engineering
05/18/2020
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and...
05/18/2020
Journal of Clinical Pathways
Data Science for HCPs
Data Engineering: The Foundation of Data Science Efforts
04/09/2020
Erwan Rivet, MBA, MSME; Victor M. Gehman, PhD; Kelly Leyden, MRes; Michael Becich, MS; Anisha Keshavan, PhD; Amal Katrib, PhD; Fatima Rubio da Costa, PhD; David Hughes, BSN; David Whewell
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and...
04/09/2020
Journal of Clinical Pathways
Data Science for HCPs
What Is Data Science: Addressing the Uncertainty Behind Addressing Uncertainty
03/14/2020
David Hughes, BSN; Victor M. Gehman, PhD; Michael Becich, MS; Amal Katrib, PhD; Fatima Rubio da Costa, PhD; David Whewell
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and...
03/14/2020
Journal of Clinical Pathways
Data Science for HCPs
Introduction to Data Science for Health Care Professionals
02/11/2020
Victor M. Gehman, PhD; Kelly Leyden, MRes; Michael Becich, MS; Anisha Keshavan, PhD; Amal Katrib, PhD; Melinda Thomas; Fatima Rubio da Costa, PhD; Michael Towbin; David Whewell; David Hughes, BSN
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the...
02/11/2020
Journal of Clinical Pathways

Healthcare Economist

Jason Shafrin, PhD
Healthcare Economist
Performance-Based Risk Sharing Agreements for Devices and Diagnostics
03/04/2022
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a...
03/04/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Distributional Cost-Effectiveness Analysis: A Simple Example
02/09/2022
Jason Shafrin, PhD
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6...
02/09/2022
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Alternative Payment Models: Where Are We Now?
02/07/2022
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a...
02/07/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Impact of Biosimilar Entry on Drug Costs
12/20/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a...
12/20/2021
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Which Strategies Are Payers and Employers Using to Cover Ophan Drugs?
06/20/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a...
06/20/2021
Journal of Clinical Pathways
Healthcare Economist
The Real Cost of Electronic Health Records
06/07/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses...
06/07/2021
Journal of Clinical Pathways
Healthcare Economist
Impact of COVID-19 on CMS’ Value-Based Programs
06/01/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses...
06/01/2021
Journal of Clinical Pathways
Healthcare Economist
PCORI to Incorporate Cost But Not Cost-Effectiveness in its New Principles
10/09/2020
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights...
10/09/2020
Journal of Clinical Pathways
Healthcare Economist
The Need for Continuous Cost-Effectiveness Analysis
07/06/2020
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a...
07/06/2020
Journal of Clinical Pathways
Healthcare Economist
Are Value-Based Agreements the Solution to High Drug Prices?
05/26/2020
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides...
05/26/2020
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Performance-Based Risk Sharing Agreements for Devices and Diagnostics
03/04/2022
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a...
03/04/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Distributional Cost-Effectiveness Analysis: A Simple Example
02/09/2022
Jason Shafrin, PhD
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6...
02/09/2022
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Alternative Payment Models: Where Are We Now?
02/07/2022
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a...
02/07/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Impact of Biosimilar Entry on Drug Costs
12/20/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a...
12/20/2021
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Which Strategies Are Payers and Employers Using to Cover Ophan Drugs?
06/20/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a...
06/20/2021
Journal of Clinical Pathways
Healthcare Economist
The Real Cost of Electronic Health Records
06/07/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses...
06/07/2021
Journal of Clinical Pathways
Healthcare Economist
Impact of COVID-19 on CMS’ Value-Based Programs
06/01/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses...
06/01/2021
Journal of Clinical Pathways
Healthcare Economist
PCORI to Incorporate Cost But Not Cost-Effectiveness in its New Principles
10/09/2020
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights...
10/09/2020
Journal of Clinical Pathways
Healthcare Economist
The Need for Continuous Cost-Effectiveness Analysis
07/06/2020
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a...
07/06/2020
Journal of Clinical Pathways
Healthcare Economist
Are Value-Based Agreements the Solution to High Drug Prices?
05/26/2020
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides...
05/26/2020
Journal of Clinical Pathways

Quality Outlook

Quality Outlook
Measuring Justice in Breast Cancer Screening: A Bioethical Framework for Analyzing Quality Measures
03/10/2026
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality...
03/10/2026
Journal of Clinical Pathways
Quality Outlook
The Rising and Setting of Health Equity
02/24/2026
David Sloan, PhD; Tom Valuck, MD, JD
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating...
02/24/2026
Journal of Clinical Pathways
Quality Outlook
Autonomy in End-of-Life Cancer Care Measurement: A Bioethical Framework for Analyzing Quality Measures
09/24/2025
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
The predominant US health care quality measure development and endorsement processes, as summarized in the Center for Medicare and Medicaid Services (CMS) Blueprint, have various well-accepted criteria for evaluating measures. This blog...
The predominant US health care quality measure development and endorsement processes, as summarized in the Center for Medicare and Medicaid Services (CMS) Blueprint, have various well-accepted criteria for evaluating measures. This blog...
The predominant US health care...
09/24/2025
Journal of Clinical Pathways
Nandita Ammanamanchi
Quality Outlook
Beneficence and Nonmaleficence in Cancer Pain Measurement: A Bioethical Framework for Analyzing Quality Measures
07/21/2025
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series explores how the twin pillars of beneficence and nonmaleficence guide more ethical and effective measurement of cancer pain, balancing patient relief with the imperative to "first, do no harm."
This entry of the Quality Outlook blog series explores how the twin pillars of beneficence and nonmaleficence guide more ethical and effective measurement of cancer pain, balancing patient relief with the imperative to "first, do no harm."
This entry of the Quality...
07/21/2025
Journal of Clinical Pathways
Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Bridget Doherty, MPH, MS; Silas Martin, MS; Tom Valuck, MD, JD
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
David Blaisdell
Quality Outlook
Measuring Adherence to Oral Anticancer Medications: A Persistent Problem
06/06/2024
Tom Valuck, MD, JD; David Blaisdell, BA
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the...
06/06/2024
Journal of Clinical Pathways
Veronica Ellis
Quality Outlook
Transform HIV Prevention in Your Practice With a New Quality Initiative
05/01/2024
Tom Valuck, MD, JD
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an...
05/01/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Tom Valuck, MD, JD
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
Tom Valuck, MD, JD; Erik Muther; Theresa Schmidt, MA, PMP, CSPO; Danny Bellet, MBA; Donna Dugan, PhD, MS; David Sloan, PhD
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Quality Outlook
Measuring Justice in Breast Cancer Screening: A Bioethical Framework for Analyzing Quality Measures
03/10/2026
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality...
03/10/2026
Journal of Clinical Pathways
Quality Outlook
The Rising and Setting of Health Equity
02/24/2026
David Sloan, PhD; Tom Valuck, MD, JD
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating...
02/24/2026
Journal of Clinical Pathways
Quality Outlook
Autonomy in End-of-Life Cancer Care Measurement: A Bioethical Framework for Analyzing Quality Measures
09/24/2025
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
The predominant US health care quality measure development and endorsement processes, as summarized in the Center for Medicare and Medicaid Services (CMS) Blueprint, have various well-accepted criteria for evaluating measures. This blog...
The predominant US health care quality measure development and endorsement processes, as summarized in the Center for Medicare and Medicaid Services (CMS) Blueprint, have various well-accepted criteria for evaluating measures. This blog...
The predominant US health care...
09/24/2025
Journal of Clinical Pathways
Nandita Ammanamanchi
Quality Outlook
Beneficence and Nonmaleficence in Cancer Pain Measurement: A Bioethical Framework for Analyzing Quality Measures
07/21/2025
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series explores how the twin pillars of beneficence and nonmaleficence guide more ethical and effective measurement of cancer pain, balancing patient relief with the imperative to "first, do no harm."
This entry of the Quality Outlook blog series explores how the twin pillars of beneficence and nonmaleficence guide more ethical and effective measurement of cancer pain, balancing patient relief with the imperative to "first, do no harm."
This entry of the Quality...
07/21/2025
Journal of Clinical Pathways
Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Bridget Doherty, MPH, MS; Silas Martin, MS; Tom Valuck, MD, JD
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
David Blaisdell
Quality Outlook
Measuring Adherence to Oral Anticancer Medications: A Persistent Problem
06/06/2024
Tom Valuck, MD, JD; David Blaisdell, BA
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the...
06/06/2024
Journal of Clinical Pathways
Veronica Ellis
Quality Outlook
Transform HIV Prevention in Your Practice With a New Quality Initiative
05/01/2024
Tom Valuck, MD, JD
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an...
05/01/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Tom Valuck, MD, JD
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
Tom Valuck, MD, JD; Erik Muther; Theresa Schmidt, MA, PMP, CSPO; Danny Bellet, MBA; Donna Dugan, PhD, MS; David Sloan, PhD
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways

Guest Blogs

Jason Shafrin, PhD, FTI Consulting
Guest Blog
Has Medicine Reached the Digital Age? Five Key Obstacles Digital Technologies Still Need to Overcome
08/26/2021
Jason Shafrin, PhD; Jason Shafrin, PhD
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David...
08/26/2021
Journal of Clinical Pathways
Guest Blog
How Cloud Computing Can Be the Key to Ameliorating Outcomes While Mitigating Health Care Costs
04/16/2021
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few...
04/16/2021
Journal of Clinical Pathways
Guest Blog
How Digital Solutions Help Drive Patient-Focused Health Care
02/18/2021
Leo P. Langlois, MD, PT
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P...
02/18/2021
Journal of Clinical Pathways
Guest Blog
Adapting Pathways in a Pandemic
05/08/2020
Gordon Kuntz
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz...
05/08/2020
Journal of Clinical Pathways
Guest Blog
Deprescribing: A Tool for Cost Reduction and Improved Outcomes?
07/11/2019
Marsha K. Millonig, MBA, BPharm
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm,...
07/11/2019
Journal of Clinical Pathways
Guest Blog
Achieving “Victory” Through Holistic Palliative Care
07/03/2019
Adil Akhtar, MD
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the...
07/03/2019
Journal of Clinical Pathways
Guest Blog
Pharmacogenomics: Preemptive Testing Decisions Reach Across the Care Team
01/07/2019
Kandace Schuft, PharmD
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD,...
01/07/2019
Journal of Clinical Pathways
Guest Blog
Health Insurance Aside, Americans Still Struggle to Pay for Their Medications
12/14/2018
Thomas Goetz, MPH
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are...
12/14/2018
Journal of Clinical Pathways
Guest Blog
Potential Administrative Burdens in Oncology Clinical Pathways
05/07/2018
Sowmya Josyula, MD, MPH; Bobby Daly, MD, MBA
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and...
05/07/2018
Journal of Clinical Pathways
Guest Blog
Why Palliative Care is More Than Just Care for the Dying
04/28/2018
Tim Holder, MD
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly...
04/28/2018
Journal of Clinical Pathways
Jason Shafrin, PhD, FTI Consulting
Guest Blog
Has Medicine Reached the Digital Age? Five Key Obstacles Digital Technologies Still Need to Overcome
08/26/2021
Jason Shafrin, PhD; Jason Shafrin, PhD
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David...
08/26/2021
Journal of Clinical Pathways
Guest Blog
How Cloud Computing Can Be the Key to Ameliorating Outcomes While Mitigating Health Care Costs
04/16/2021
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few...
04/16/2021
Journal of Clinical Pathways
Guest Blog
How Digital Solutions Help Drive Patient-Focused Health Care
02/18/2021
Leo P. Langlois, MD, PT
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P...
02/18/2021
Journal of Clinical Pathways
Guest Blog
Adapting Pathways in a Pandemic
05/08/2020
Gordon Kuntz
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz...
05/08/2020
Journal of Clinical Pathways
Guest Blog
Deprescribing: A Tool for Cost Reduction and Improved Outcomes?
07/11/2019
Marsha K. Millonig, MBA, BPharm
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm,...
07/11/2019
Journal of Clinical Pathways
Guest Blog
Achieving “Victory” Through Holistic Palliative Care
07/03/2019
Adil Akhtar, MD
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the...
07/03/2019
Journal of Clinical Pathways
Guest Blog
Pharmacogenomics: Preemptive Testing Decisions Reach Across the Care Team
01/07/2019
Kandace Schuft, PharmD
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD,...
01/07/2019
Journal of Clinical Pathways
Guest Blog
Health Insurance Aside, Americans Still Struggle to Pay for Their Medications
12/14/2018
Thomas Goetz, MPH
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are...
12/14/2018
Journal of Clinical Pathways
Guest Blog
Potential Administrative Burdens in Oncology Clinical Pathways
05/07/2018
Sowmya Josyula, MD, MPH; Bobby Daly, MD, MBA
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and...
05/07/2018
Journal of Clinical Pathways
Guest Blog
Why Palliative Care is More Than Just Care for the Dying
04/28/2018
Tim Holder, MD
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly...
04/28/2018
Journal of Clinical Pathways

Payer Voice

Quality Outlook
Measuring Justice in Breast Cancer Screening: A Bioethical Framework for Analyzing Quality Measures
03/10/2026
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality...
03/10/2026
Journal of Clinical Pathways
Quality Outlook
The Rising and Setting of Health Equity
02/24/2026
David Sloan, PhD; Tom Valuck, MD, JD
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating...
02/24/2026
Journal of Clinical Pathways
Quality Outlook
Autonomy in End-of-Life Cancer Care Measurement: A Bioethical Framework for Analyzing Quality Measures
09/24/2025
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
The predominant US health care quality measure development and endorsement processes, as summarized in the Center for Medicare and Medicaid Services (CMS) Blueprint, have various well-accepted criteria for evaluating measures. This blog...
The predominant US health care quality measure development and endorsement processes, as summarized in the Center for Medicare and Medicaid Services (CMS) Blueprint, have various well-accepted criteria for evaluating measures. This blog...
The predominant US health care...
09/24/2025
Journal of Clinical Pathways
Nandita Ammanamanchi
Quality Outlook
Beneficence and Nonmaleficence in Cancer Pain Measurement: A Bioethical Framework for Analyzing Quality Measures
07/21/2025
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series explores how the twin pillars of beneficence and nonmaleficence guide more ethical and effective measurement of cancer pain, balancing patient relief with the imperative to "first, do no harm."
This entry of the Quality Outlook blog series explores how the twin pillars of beneficence and nonmaleficence guide more ethical and effective measurement of cancer pain, balancing patient relief with the imperative to "first, do no harm."
This entry of the Quality...
07/21/2025
Journal of Clinical Pathways
Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Bridget Doherty, MPH, MS; Silas Martin, MS; Tom Valuck, MD, JD
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
David Blaisdell
Quality Outlook
Measuring Adherence to Oral Anticancer Medications: A Persistent Problem
06/06/2024
Tom Valuck, MD, JD; David Blaisdell, BA
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the...
06/06/2024
Journal of Clinical Pathways
Veronica Ellis
Quality Outlook
Transform HIV Prevention in Your Practice With a New Quality Initiative
05/01/2024
Tom Valuck, MD, JD
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an...
05/01/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Tom Valuck, MD, JD
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
Tom Valuck, MD, JD; Erik Muther; Theresa Schmidt, MA, PMP, CSPO; Danny Bellet, MBA; Donna Dugan, PhD, MS; David Sloan, PhD
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
News
Translating Hypertension Guidelines Into Scalable Care Pathways
03/16/2026
Hannah Musick
Clarifying the distinct roles of clinical practice guidelines, treatment protocols, and care pathways may help health systems translate hypertension evidence into standardized primary care programs that improve blood pressure control and...
Clarifying the distinct roles of clinical practice guidelines, treatment protocols, and care pathways may help health systems translate hypertension evidence into standardized primary care programs that improve blood pressure control and...
Clarifying the distinct roles of...
03/16/2026
Journal of Clinical Pathways
News
Geographic Barriers Limit CAR T-Cell Therapy Access in US Medicare Patients With DLBCL
03/12/2026
Grace Taylor, MS, MA
A SEER-Medicare analysis in Blood Advances reveals that geographic distance and socioeconomic status significantly shape CAR T access and survival outcomes for US patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
A SEER-Medicare analysis in Blood Advances reveals that geographic distance and socioeconomic status significantly shape CAR T access and survival outcomes for US patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
A SEER-Medicare analysis in...
03/12/2026
Journal of Clinical Pathways
Quality Outlook
Measuring Justice in Breast Cancer Screening: A Bioethical Framework for Analyzing Quality Measures
03/10/2026
Nandita Ammanamanchi, BA; Rachel Delinger, MPH; David Blaisdell, BA; Tom Valuck, MD, JD
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality Outlook blog series applies a bioethical justice framework to evaluate breast cancer screening quality measures, highlighting how equity-oriented analysis can uncover access disparities, inform measure refinement,...
This entry of the Quality...
03/10/2026
Journal of Clinical Pathways
News
Social Drivers Linked to Hepatocellular Carcinoma Stage and Survival in US Integrated Care System
03/09/2026
Hannah Musick
In a large integrated US health system, Asian and Pacific Islander patients with hepatocellular carcinoma (HCC) had lower odds of advanced-stage diagnosis and better 5-year survival, while residence in socioeconomically deprived neighborhoods...
In a large integrated US health system, Asian and Pacific Islander patients with hepatocellular carcinoma (HCC) had lower odds of advanced-stage diagnosis and better 5-year survival, while residence in socioeconomically deprived neighborhoods...
In a large integrated US health...
03/09/2026
Journal of Clinical Pathways
News
FDA Approves Pembrolizumab Plus Paclitaxel for Platinum-Resistant Ovarian Cancer in the US
03/06/2026
Hannah Musick
The US Food and Drug Administration (FDA) has approved pembrolizumab in combination with paclitaxel ± bevacizumab for PD-L1–positive platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma, based on improved...
The US Food and Drug Administration (FDA) has approved pembrolizumab in combination with paclitaxel ± bevacizumab for PD-L1–positive platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma, based on improved...
The US Food and Drug...
03/06/2026
Journal of Clinical Pathways
News
Real-World Data Support Earlier T-DXd Use in HR+/HER2-Low Metastatic Breast Cancer
03/04/2026
Grace Taylor, MS, MA
Earlier use of trastuzumab deruxtecan (T-DXd) in hormone receptor-positive (HR+)/ human epidermal growth factor receptor 2 (HER2)-low metastatic breast cancer was associated with longer real-world treatment duration and delayed need for...
Earlier use of trastuzumab deruxtecan (T-DXd) in hormone receptor-positive (HR+)/ human epidermal growth factor receptor 2 (HER2)-low metastatic breast cancer was associated with longer real-world treatment duration and delayed need for...
Earlier use of trastuzumab...
03/04/2026
Journal of Clinical Pathways
Ovarian cancer, Rosella trial
Videos
Advancing Treatment in Platinum-Resistant Ovarian Cancer: Clinical Impact of the ROSELLA Trial
03/03/2026
Robert L. Colemen, MD, FACOG, FACS
Robert Coleman, MD, discusses how the phase 3 ROSELLA trial showed that relacorilant plus nab-paclitaxel significantly improved overall survival in patients with platinum-resistant ovarian cancer.
Robert Coleman, MD, discusses how the phase 3 ROSELLA trial showed that relacorilant plus nab-paclitaxel significantly improved overall survival in patients with platinum-resistant ovarian cancer.
Robert Coleman, MD, discusses...
03/03/2026
Journal of Clinical Pathways
Non-small cell lung cancer, NSCLC
Videos
Examining Equity Gaps in Immune Checkpoint Inhibitor Trials for NSCLC
02/25/2026
Adam Barsouk, MD
Adam A. Barsouk, MD, discusses how underrepresentation in NSCLC immunotherapy trials continues to influence survival outcomes and what must change to achieve more equitable care.
Adam A. Barsouk, MD, discusses how underrepresentation in NSCLC immunotherapy trials continues to influence survival outcomes and what must change to achieve more equitable care.
Adam A. Barsouk, MD, discusses...
02/25/2026
Journal of Clinical Pathways
Quality Outlook
The Rising and Setting of Health Equity
02/24/2026
David Sloan, PhD; Tom Valuck, MD, JD
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating health equity into value-based care, recent federal policy changes are reshaping how disparities are measured, reported, and addressed across the US health system.
After years of integrating...
02/24/2026
Journal of Clinical Pathways
eNews Sign-up

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use